Pfizer and Humedica have formed a multi-year strategic partnership to jointly advance capabilities to receive insights from real world data. As part of the alliance, the companies will conduct data-driven collaborative research to ...
Tags: Humedica, Pfizer Collaborate, Data Driven
Nuron Biotech has secured $80m finance from HealthCare Royalty Partners to support the commercialization and expansion of its Meningitec, a recently acquired vaccine from Pfizer. Meningitec is an established commercial vaccine to prevent ...
Tags: Nuron Biotech, secured finance, vaccine, Meningitec, commercial vaccine
US-based Omni Bio Pharmaceutical has named Bruce Schneider as the company's new chief executive officer (CEO), effective 1 January 2013. Omni Bio is involved in developing alternative uses of Alpha-1 antitrypsin (AAT), designed for ...
Tags: Pharmaceutical, New CEO, Omni Bio, AAT
There were, despite continued economic uncertainty in many Western markets and concerns over slowing growth in the East, signs that M&A activity rebounded in the food sector this year. Data for the whole of 2012 has not yet been published ...
Tags: European M&A advisors, food sector, Food
Cyber criminals are using compromised Twitter accounts to distribute messages disguised as coming from friends who suggest recipients click on a link to see themselves on a Facebook video. Sophos reported the trick after receiving a ...
Tags: Direct message virus, Facebook, LinkedIn, Malicious links, social media
While shopping for your Thanksgiving edibles this week, you might notice store shelves are already decked out with products and packaging aimed toward the next holiday—you know the one associated with trimmed trees, reindeer and a ...
Tags: Holiday Packaging, Red Bull, ChapStick
Pfizer and Ligand Pharmaceuticals have announced the FDA acceptance of bazedoxifene/conjugated estrogens (BZA/CE) new drug application (NDA) for review. The BZA/CE is an investigational therapy developed by Wyeth Pharmaceuticals to tackle ...
Tags: estrogens NDA, Pharmaceuticals, FDA, menopausal symptoms
(i) GDP Data In 2005, the GDP of Liaoning province reached RMB800.5 billion yuan, the proportion of the primary industry, the secondary and the tertiary industry was 6.1%, 60.7% and 33.2% respectively, and the per-capita GDP was RMB18, ...
Tags: Liaoning Province, survey, economy, investment
Israel-based Protalix BioTherapeutics has signed an agreement with Pfizer to continue managing the development activities of Gaucher disease drug Elelyso. According to the clinical development agreement, Protalix will continue to manage ...
Tags: Protalix, Pfizer, Gaucher disease drug
The FDA Arthritis Advisory Committee has recommended the approval of Pfizer's Tofacitinib for adult patients with moderately to severely active rheumatoid arthritis (RA). The recommendation will be considered by the FDA in its review of ...
Tags: RA, tofacitinib, rheumatoid arthritis
Mylan has been sued jointly by Pfizer,Wyeth Pharmaceutical,Wyeth LLC and PF Prism regarding the filing of an abbreviated new drug application (ANDA) with the US food and drug administration (FDA) for desvenlafaxine succinate ...
Tags: Mylan, desvenlafaxine succinate extended-release tablets, MDD
Swiss food company Nestlé's $11.85bn deal to acquire Pfizer's infant nutrition business has received approval from the Chinese Ministry of Commerce, a move which brings the company closer to completing the acquisition. ...
Tags: infant nutrition business, anti-trust bodies, baby food market
The Competition Commission of India (CCI) has approved Nestlé's proposed acquisition of Pfizer Nutrition business. CCI said that considering the instance that Pfizer is not involved in the Indian nutrition marketplace, it is not ...
Tags: acquisition, nutrition marketplace, business of nutrition
The European Commission has granted conditional marketing authorization for Pfizer’s Xalkori (crizotinib) to treat anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) in the European Union (EU). ...
Tags: Xalkori, crizotinib, anaplastic lymphoma kinase, ALK
US Food and Drug Administration (FDA) has approved Pfizer's Bosulf (bosutinib) to treat adult patients with chronic, accelerated or blast phase Philadelphia chromosome-positive (Ph+) (CML) with resistance to prior therapy. Bosulif is a ...
Tags: bosulf, bosutinib, kinase inhibitor, Philadelphia chromosome-positive